Fluoxetine decreases brain temperature and REM sleep in Syrian hamsters.
The antidepressant drug, fluoxetine (FLX), a selective serotonin reuptake inhibitor, was administered to Syrian hamsters, and its acute and chronic effects on EEG sleep and hypothalamic temperature were recorded. Acute fluoxetine treatment at doses of 5, 10, 20 and 40 mg/kg decreased REM sleep and hypothalamic temperature in a dose-dependent manner. It increased NREM sleep, and, at doses of 20 and 40 mg/kg, it increased wakefulness. At 40 mg/kg, it decreased motor activity. During chronic treatment, tolerance developed to FLX's REM sleep-inhibiting effects, but tolerance did not develop to FLX's hypothalamic temperature-decreasing effects. Chronic FLX treatment produced circadian phase-dependent decreases in temperature beyond those that were observed during acute treatment. The apparent dissociation during chronic treatment between FLX's temperature-lowering effects and its REM-decreasing effects might be related to long-term changes in 5HT receptor function or FLX pharmacokinetics.
Gao
B
B
Clinical Psychobiology Branch, National Institute of Mental Health, Bethesda, MD 20892.
Duncan
W C
WC
Wehr
T A
TA
D000818:Animals; D001143:Arousal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects*; D001921:Brain / Q000502:physiology*; D002940:Circadian Rhythm / Q000187:drug effects; D006224:Cricetinae; D003864:Depression, Chemical; D004569:Electroencephalography; D005473:Fluoxetine / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology; D008297:Male; D008647:Mesocricetus; D009043:Motor Activity / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects*
D005473:Fluoxetine